Venkat R. Pallela

Design, synthesis, and biological evaluation of 1-(4-sulfamylphenyl)-3-trifluoromethyl-5-indolyl pyrazolines as cyclooxygenase-2 (COX-2) and lipoxygenase (LOX) inhibitors

M. V. Ramana Reddy, Vinay K. Billa, Venkat R. Pallela et al. · Bioorganic & Medicinal Chemistry · 2008 · 114 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Discovery of a Clinical Stage Multi-Kinase Inhibitor Sodium (<i>E</i>)-2-{2-Methoxy-5-[(2′,4′,6′-trimethoxystyrylsulfonyl)methyl]phenylamino}acetate (ON 01910.Na): Synthesis, Structure–Activity Relationship, and Biological Activity

M. V. Ramana Reddy, Muralidhar R. Mallireddigari, Venkat R. Pallela et al. · Journal of Medicinal Chemistry · 2011 · 95 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of 8-Cyclopentyl-2-[4-(4-methyl-piperazin-1-yl)-phenylamino]-7-oxo-7,8-dihydro-pyrido[2,3-<i>d</i>]pyrimidine-6-carbonitrile (<b>7x</b>) as a Potent Inhibitor of Cyclin-Dependent Kinase 4 (CDK4) and AMPK-Related Kinase 5 (ARK5)

M. V. Ramana Reddy, Balireddy Akula, Stephen C. Cosenza et al. · Journal of Medicinal Chemistry · 2014 · 71 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

99mTc-labeled vasoactive intestinal peptide receptor agonist: functional studies.

Venkat R. Pallela, Mathew L. Thakur, Sushanta Chakder et al. · PubMed · 1999 · 62 citations

Medicine, Nuclear Medicine, Pharmacology +17

99mTc-labeled vasoactive intestinal peptide analog for rapid localization of tumors in humans.

Mathew L. Thakur, Carol S. Marcus, Saba Saeed et al. · PubMed · 2000 · 62 citations

Medicine, Oncology, Pharmacokinetics +15